295 reports of suspected side effects of implants in 2023 In 2023, 295 individuals reported one or more suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI).
RIVM identifies three major challenges for public health and healthcare in period to 2050 The Dutch public health and healthcare will face three crucial challenges in the period to 2050. This is according to RIVM’s preview of the Dutch Public Health Foresight Study 2024.
Smokers inhale more tar, nicotine and carbon monoxide when measured with WHO method RIVM has measured the amount of tar, nicotine and carbon monoxide (TNCO) in all filter cigarettes sold in the Netherlands with the WHO Intense method.
MEBI: 193 reports of suspected side effects of implants in 2022 In 2022, 193 individuals reported suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI). Most reports received concerned breast implants, copper IUDs and wrinkle fillers. This is highlighted in MEBI’s annual report.
Darker cigarettes and other measures to make cigarettes less appealing There are a number of measures that can be implemented to make cigarettes less appealing and less addictive. For example, manufacturers could make cigarettes a darker colour. They could also stop using ingredients like sugars and flavourings.
Mpox vaccinations in 2022 More than 18 thousand people in the Netherlands have received one or more mpox vaccinations. The vaccination campaign was launched late last July, shortly after the outbreak began, and ended last month. Science Photo Library / ANP
Vaccination campaign to end as number of monkeypox infections consistently low The current monkeypox outbreak is virtually over, and therefore the vaccination campaign to stop the spread of monkeypox, or ‘apenpokken’ in Dutch, will soon be coming to an end.
One-third of target group now vaccinated against monkeypox 10,440 monkeypox vaccinations have already been administered in the Netherlands in the last few weeks. That represents about one-third of the target group currently eligible to get the vaccine against monkeypox. Science Photo Library / ANP
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
Number of monkeypox infections continues to rise More than 16,000 cases of monkeypox have now been confirmed worldwide, spread across 75 countries. Both the number of confirmed cases and the number of countries where the disease is present are continuing to rise